small molecule

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Loss of exclusivityApril 2029latest FDA-listed patent expiry
CompanyRockwell Medical →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIFERIC
Active ingredientFERRIC PYROPHOSPHATE CITRATE
Strength27.2MG IRON/5ML (5.44MG IRON/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2015
Marketing statusDISCN

Listed patents

PatentExpiresType
7816404April 2029product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.